APVO icon

Aptevo Therapeutics
APVO

2 hedge funds and large institutions have $1.13M invested in Aptevo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$440K
2
+$408K

Top Sellers

1
-$367K
2
-$334K
3
-$211K
4
Renaissance Technologies
Renaissance Technologies
New York
-$117K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$77.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$440K
2
$408K
3
$73K
4
$58K
5
$47.1K
6
$24.9K
7
$18.6K
8
$16K
9
$15.7K
10
$4.66K
11
$4.45K
12
$3.63K
13
$3.63K
14
$3.61K
15
$3.3K
16
$629
17
$515
18
$96
19
$47
20
$31
21
$28
22
$9
23
$6
24
$5
25
$3
1
2